<DOC>
	<DOCNO>NCT02325063</DOCNO>
	<brief_summary>The primary objective study compare evolution pain profile among patient suffer lateral epicondyalgia ( tennis elbow ) follow three type treatment : PRP-L injection versus type A botulinum toxin injection versus corticoid injection .</brief_summary>
	<brief_title>Evaluation Three Types Injection Treatment Lateral Epicondylalgia</brief_title>
	<detailed_description>The secondary objective compare follow among three group : A- The global efficacy treatment define minimum reduction 25 % average pain last 24 hour 0 6 month . B- The evolution average pain last 24 hour 0 different time frame ( 3 week , 6 week , 3 month 6 month ) . C- The evolution maximum pain score use nocturnal post-effort ( Jamar grip test ) visual analog scale ( VAS ) day 0 , 3 week , 6 week , 3 month 6 month . D- The perception change Patient 's Global Impression Change score ( PGIC ) 3 6 month E- The evolution PRTEE score 0 , 3 6 month F- Adverse event 3 week , 6 week , 3 month 6 month . G - Quality life utility via SF-12 3 6 month . H- The consumption analgesic .</detailed_description>
	<mesh_term>Tennis Elbow</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>General inclusion criterion : The patient must give free informed consent sign consent The patient must affiliate beneficiary health insurance plan The patient available 6 month followup Woman childbearing age use contraception Inclusion criterion target population : patient side epicondylalgia objectify : Clinical criterion : symptom last 6 week less 12 month . The list symptoms present : pain palpation lateral epicondyle , pain lateral epicondyle block contraction Therapeutic : less two injection corticosteroid perform , last injection perform least 3 month inclusion General noninclusion criterion : The patient participate another study The patient exclusion period determine previous study The patient judicial protection The patient guardianship curatorship The patient refuse sign consent Woman childbearing age use contraception Impossible correction inform patient study Noninclusion criterion investigational auxiliary medicinal product : The patient least one contraindication list SPC Xeomin ALTIM : Hypersensitivity Botulinum neurotoxin type A Cortivazol Hypersensitivity excipients use composition XEOMIN ( Human albumin , sucrose ) / ALTIM ( Benzyl alcohol , carmellose sodium , sodium chloride , cetylpyridinium chloride , polysorbate 80 ) Generalized disorder muscle activity ( eg myasthenia gravis , LambertEaton syndrome ) . Severe coagulation disorder , anticoagulation progress ( ticlopidine , clopidogrel , antiplatelet antithrombotic agent ) Presence local general infection , suspect infection , infection propose injection site . Noninclusion criteria medical device use PRP sample ( SmartPReP2 sample system ) : Clinical laboratory evidence sepsis Taking aspirin drug alter platelet function previous 3 day Patient platelet dysfunction disorder Noninclusion criterion interfere disease condition : The patient pregnant , parturient breastfeed The patient allergy botulinum toxin type A / glucocorticoids The patient medial epicondylalgia The patient history elbow surgery The patient follow condition : immunodeficiency , rheumatic disease , hepatitis , diabetes , another disease ipsilateral limb , neurological disorder ( radiculopathy , compression radial nerve ) , myopathy ( etiology ) The patient receive treatment corticosteroid last 3 month The patient treat longterm antiplatelet medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>